Correlation Between Kiora Pharmaceuticals and X4 Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and X4 Pharmaceuticals, you can compare the effects of market volatilities on Kiora Pharmaceuticals and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and X4 Pharmaceuticals.

Diversification Opportunities for Kiora Pharmaceuticals and X4 Pharmaceuticals

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Kiora and XFOR is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and X4 Pharmaceuticals go up and down completely randomly.

Pair Corralation between Kiora Pharmaceuticals and X4 Pharmaceuticals

Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to under-perform the X4 Pharmaceuticals. In addition to that, Kiora Pharmaceuticals is 1.01 times more volatile than X4 Pharmaceuticals. It trades about -0.03 of its total potential returns per unit of risk. X4 Pharmaceuticals is currently generating about 0.0 per unit of volatility. If you would invest  120.00  in X4 Pharmaceuticals on August 27, 2024 and sell it today you would lose (86.00) from holding X4 Pharmaceuticals or give up 71.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Kiora Pharmaceuticals  vs.  X4 Pharmaceuticals

 Performance 
       Timeline  
Kiora Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kiora Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Kiora Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
X4 Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days X4 Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Kiora Pharmaceuticals and X4 Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kiora Pharmaceuticals and X4 Pharmaceuticals

The main advantage of trading using opposite Kiora Pharmaceuticals and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.
The idea behind Kiora Pharmaceuticals and X4 Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets